Royal Capital Wealth Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,592
Closed -$204K 98
2022
Q4
$204K Buy
+2,592
New +$194K 0.22% 94
2022
Q3
Sell
-2,744
Closed -$220K 90
2022
Q2
$220K Buy
2,744
+4
+0.1% +$313 0.24% 85
2022
Q1
$208K Buy
2,740
+4
+0.1% +$317 0.2% 95
2021
Q4
$233K Buy
+2,736
New +$214K 0.23% 90

Other funds holding CL

Royal Capital Wealth Management's CL Position: Q1 2023 in Review

Royal Capital Wealth Management sold out of Colgate-Palmolive (CL) in Q1 2023, closing a stake of 2,592 shares — an estimated $204K sold.

Royal Capital Wealth Management first reported a position in CL in Q4 2021 and held it in 4 quarters. The position peaked at $233K in Q4 2021. 1,657 funds tracked by Wall St. Rank hold CL as of Q1 2023.

  • Royal Capital Wealth Management reported no remaining Colgate-Palmolive position as of Q1 2023 after selling out during the quarter.
  • Royal Capital Wealth Management sold 2,592 Colgate-Palmolive shares in Q1 2023, an estimated $204K.
  • Royal Capital Wealth Management first reported a position in Colgate-Palmolive in Q4 2021 and held it in 4 quarters.
  • Royal Capital Wealth Management's Colgate-Palmolive position peaked at $233K in Q4 2021.
  • 1,657 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2023.

Based on Royal Capital Wealth Management's 13F filing for Q1 2023, filed 12 May 2023.